Actions - Biotech
Retour à Hiérarchie Stratégique – Actions & OPCVM
Rang Tech. | Actions | Cours | Synthèse Technique | Momentums | Accé- léra- tion | Tac- tique | ROBO Analyse | Secteurs | PER (X) | Rendt (%) | Croiss. BPA | Croiss. CFA | Croiss. BKV | Croiss. Ventes | Marge Nette | Rentab. Cap.Inv | Dettes ebitda | Tickers | Capi. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Absolu | Relatif | |||||||||||||||||||
65 | Swed. Orphan Bio | 281.8 | ++++ | +++ | +++ | Neutre | Biotech | 26.2 X | 0.0% | ++ | +++ | + | ++++ | +++ | - | - | SOBI | MID | ||
65 | Taux = + 20% | ++++ | +++++ | |||||||||||||||||
44 | Pluvalca Health Opport. A | 113.7 | +++ | ++++ | Neutre | Neutre | ||||||||||||||
17 | Tx ESTER j/j rate | + | ++ | |||||||||||||||||
0 | Taux ZERO | Neutre | Neutre | |||||||||||||||||
-6 | Franklin Biotech Discovery A | 41.10 | Neutre | + | - - | - | ||||||||||||||
-15 | Candriam Eqties. L Biotech C | 830.1 | - | Neutre | - - - | Neutre | ||||||||||||||
-25 | Genmab A/S | 2?022.4 | - - | - | - - - | Neutre | Biotech | 30.0 X | 0.0% | + | +++++ | +++++ | ++++ | +++++ | GMA | BIG | ||||
-56 | Taux = - 5% | - - - | - - - | |||||||||||||||||
-67 | CS L Digital Health Eqt. B | 614.6 | - - - - | - - - | - - - - | Neutre |